Privileged structure-based ligands for melanocortin receptors-tetrahydroquinolines, indoles, and aminotetralines.
Substitution of the aryl sulfonamide moiety contained in MC4 agonist 1 with bicyclic heterocycles and aminotetralines produced compounds with MC4 activity. The heterocycles represent alternative privileged structures to that contained in 1. Compounds in which the polar group of the privileged structure was displayed in an endocyclic fashion were not as active as the parent agonist 1, while those with an exocyclic polar group afforded activity competitive with 1.
Fisher
Matthew J
MJ
Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46258, USA. fisher_matthew_j@lilly.com
Backer
Ryan T
RT
Husain
Saba
S
Hsiung
Hansen M
HM
Mullaney
Jeffrey T
JT
O'Brian
Thomas P
TP
Ornstein
Paul L
PL
Rothhaar
Roger R
RR
Zgombick
John M
JM
Briner
Karin
K
D006801:Humans; D007211:Indoles / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D008024:Ligands; D015394:Molecular Structure; D011804:Quinolines / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D044101:Receptors, Melanocortin / Q000187:drug effects* / Q000378:metabolism; D013764:Tetrahydronaphthalenes / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*
D007211:Indoles; D008024:Ligands; D011804:Quinolines; D044101:Receptors, Melanocortin; D013764:Tetrahydronaphthalenes